Memory T cells in cancer immunotherapy: which CD8+ T-cell population provides the best protection against tumours?

  1. R. Perret,
  2. F Ronchese*

Article first published online: 9 JUL 2008

DOI: 10.1111/j.1399-0039.2008.01088.x

Issue

Tissue Antigens

Tissue Antigens

Volume 72, Issue 3, pages 187–194, September 2008

Additional Information

How to Cite

Perret, R. and Ronchese, F. (2008), Memory T cells in cancer immunotherapy: which CD8+ T-cell population provides the best protection against tumours?. Tissue Antigens, 72: 187–194. doi: 10.1111/j.1399-0039.2008.01088.x

Author Information

  1. Malaghan Institute of Medical Research, Wellington, New Zealand

*Franca Ronchese Malaghan Institute of Medical Research Wellington New Zealand Tel: +64 4 499 6914 Fax: +64 4 499 6915 e-mail: fronchese@malaghan.org.nz

Publication History

  1. Issue published online: 13 AUG 2008
  2. Article first published online: 9 JUL 2008
  3. Received 3 June 2008; accepted 3 June 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (275K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lucy Wentworth, Justin V. Meyers, Sheeba Alam, Andrew J. Russ, M. Suresh, Clifford S. Cho, Memory T cells are uniquely resistant to melanoma-induced suppression, Cancer Immunology, Immunotherapy, 2013, 62, 1, 149

    CrossRef

  2. 2
    Maria Muccioli, Caitlin Longstaff, Fabian Benencia, Absence of CD4 T-cell help provides a robust CD8 T-cell response while inducing effective memory in a preclinical model of melanoma, Immunotherapy, 2012, 4, 5, 477

    CrossRef

  3. 3
    Mark P. Rubinstein, Colleen A. Cloud, Tracy E. Garrett, Caitlin J. Moore, Kristina M. Schwartz, C. Bryce Johnson, David H. Craig, Mohamed L. Salem, Chrystal M. Paulos, David J. Cole, Ex Vivo Interleukin-12-Priming During CD8+ T Cell Activation Dramatically Improves Adoptive T Cell Transfer Antitumor Efficacy in a Lymphodepleted Host, Journal of the American College of Surgeons, 2012, 214, 4, 700

    CrossRef

  4. 4
    Debora Martorelli, Giuseppe Coppotelli, Elena Muraro, Riccardo Dolcetti, Maria G. Masucci, Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cells, Cancer Immunology, Immunotherapy, 2012, 61, 6, 881

    CrossRef

  5. 5
    Hua Liu, Recent Advances in Cancer Research and Therapy, 2012,

    CrossRef

  6. 6
    Elena Muraro, Debora Martorelli, Elisa Turchet, Gianmaria Miolo, Simona Scalone, Elisa Comaro, Renato Talamini, Katy Mastorci, Davide Lombardi, Tiziana Perin, Antonino Carbone, Andrea Veronesi, Diana Crivellari, Riccardo Dolcetti, A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies, Breast Cancer Research, 2011, 13, 6, R117

    CrossRef

  7. 7
    Katelyn T. Byrne, Anik L. Côté, Peisheng Zhang, Shannon M. Steinberg, Yanxia Guo, Rameeza Allie, Weijun Zhang, Marc S. Ernstoff, Edward J. Usherwood, Mary Jo Turk, Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma, Journal of Clinical Investigation, 2011, 121, 5, 1797

    CrossRef

  8. 8
    C. Ma, X. Dong, Colorectal Cancer–Derived Foxp3+IL-17+ T Cells Suppress Tumour-Specific CD8+ T Cells, Scandinavian Journal of Immunology, 2011, 74, 1
    Direct Link:
  9. 9
    Mitsuru Sakakibara, Tatsuya Kanto, Michiyo Hayakawa, Shoko Kuroda, Hideki Miyatake, Ichiyo Itose, Masanori Miyazaki, Naruyasu Kakita, Koyo Higashitani, Tokuhiro Matsubara, Naoki Hiramatsu, Akinori Kasahara, Tetsuo Takehara, Norio Hayashi, Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide, Cancer Immunology, Immunotherapy, 2011, 60, 11, 1565

    CrossRef

  10. 10
    Hugo-Guillermo Ternavasio-de la Vega, Virginia Velasco-Tirado, Laura Pozo-Rosado, María-Carmen Soler-Fernández, Martín Pérez-Andres, Alberto Orfao, Rafael Sánchez-Sánchez, Luis González-Villaron, Persistence of immunological alterations after thymectomy in Good's syndrome: A clue to its pathogenesis, Cytometry Part B: Clinical Cytometry, 2011, 80B, 5
    Direct Link:
  11. 11
    Eugene V Barsov, Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy, Immunotherapy, 2011, 3, 3, 407

    CrossRef

  12. 12
    Anne-Marie Rasmussen, Gabriel Borelli, Hanna Julie Hoel, Kari Lislerud, Gustav Gaudernack, Gunnar Kvalheim, Tanja Aarvak, Ex vivo expansion protocol for human tumor specific T cells for adoptive T cell therapy, Journal of Immunological Methods, 2010, 355, 1-2, 52

    CrossRef

  13. 13
    Min-Ji Park, Eun-Kyung Kim, Ji-Young Han, Hyun-Woo Cho, Hyun-Jung Sohn, Su-Yeon Kim, Tai-Gyu Kim, Fusion of the Human Cytomegalovirus pp65 Antigen with Both Ubiquitin and Ornithine Decarboxylase Additively Enhances Antigen Presentation to CD8+T Cells in Human Dendritic Cells, Human Gene Therapy, 2010, 21, 8, 957

    CrossRef

View Full Article (HTML) Get PDF (275K)